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Abstract
Introduction Few series compare endoscopic third ven-
triculostomies (ETV) and ventriculoperitoneal shunts
(VPS). To avoid the complications after a shunt insertion,
there is an increased tendency to perform a third ventricu-
lostomy. We reviewed all pediatric patients operated in the
French-speaking part of Switzerland for a newly diagnosed
obstructive hydrocephalus since 1992 and compared the
outcome of patients who benefited from ETV to the
outcome of patients who benefited from VPS. There were
24 ETV and 31 VPS.
Discussion At 5 years of follow-up, the failure rate of ETV
was 26%, as compared to 42% for the VPS group. This
trend is also found in the pediatric series published since
1990 (27 peer-reviewed articles analyzed).
Conclusion In accordance to this trend, although a statis-
tical difference cannot be assessed, we believe that ETV
should be the procedure of choice in pediatric obstructive
hydrocephalus.
Keywords Pediatric . Hydrocephalus . Ventriculostomy .
Ventriculoperitoneal shunt
Introduction
In the last decades, endoscopic third ventriculostomy
(ETV) has become the procedure of choice in the treatment
of pediatric obstructive hydrocephalus in many centers,
replacing ventriculoperitoneal shunts (VPS). Even if the
procedures might seem simple, the pathophysiology of
hydrocephalus is complex and probably not completely
understood; therefore, management of patients with hydro-
cephalus can be challenging. Since the introduction of the
shunt, many new materials have been developed, with each
development bringing the hope that the new materials will
lead to a better outcome. Some surgeons think that
endoscopic third ventriculoscopy was the key to success
in the cure of hydrocephalus, but does its outcome confirm
that thought? Many articles have been published
concerning the mortality and morbidity, as well as the
outcome, of both approaches. Ventriculo-atrial and VPS
have been compared, as well as different types of valves for
VPS, but the comparison between third ventriculostomies
and cerebrospinal fluid shunts has rarely been addressed.
We studied all pediatric patients diagnosed with obstruc-
tive hydrocephalus who were treated in Geneva or
Lausanne, Switzerland since 1990. After analyzing the
two groups, their outcome and failure rate, we retrieved the
last pediatric series published in peer-reviewed literature
(on ventriculostomy or VPS from 1990 to June 2006) to
compare the two procedures and to see if a difference could
be seen in their outcomes. A strict meta-analysis of those
series is not possible, as there are, for the moment, no
randomized controlled trials.
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All pediatric patients (0–18 years old) who were diagnosed
and treated for the first time for obstructive hydrocephalus,
in Lausanne or Geneva, Switzerland, from January 1990 to
December 2004 were retrospectively analyzed. There were
24 ETV and 31 VPS performed. Data were analyzed with
respect to etiology of hydrocephalus, age, and gender. We
compared the operative indications, and in the case of
failure, the mean time before revision, the causes of
failures, and their risk factors. Failure was defined as the
need of a surgical intervention, and included shunt revision,
placement of a new shunt, or a new ventriculostomy.
The literature was reviewed using PubMed and Embase,
from 1990 to June 2006 with the key words “obstructive
hydrocephalus” and “pediatric”, in peer-reviewed journals.
Tables of content of the major pediatric neurosurgical
journals (Child’s Nervous System, Journal of Neurosurgery:
Pediatrics, and Pediatric Neurosurgery) were reviewed as
well from 2000 to 2006. All pediatric series that involved
more than ten patients and analyzed either third ventricu-
lostomy, shunt procedures, or both were included. Articles
describing a technique or only focusing on a special type of
complication were not included, unless the general success
rate (or failure) and follow-up time were stated. When
different articles were written with the same or only slightly
different population (for example two studies in the same
center overlapping), only one of the articles was included to
avoid including the same patients twice. If a series mixed
pediatric and adult patients, it was discarded, unless the
pediatric population was easily identified. If a series
included both obstructive and communicating hydrocepha-
lus, we would consider it only if there was a majority of
obstructive patients or if we could separately analyze
obstructive patients. In series that included first-time shunts
and revisions, we only accounted for the first-time surgery
when that was possible. A total of 27 studies were retrieved
and included.
Data were analyzed using Student’s t-test, Kaplan–
Meier, and analysis of variance (Statistica 6.0, StatSoft).
Results
There was a total of 48 patients included. Seven of them
had both procedures; therefore, there were 55 new
procedures. The mean age of the total population was
4.6 years old (median 8.8 months, 1 day to 17 years).
Twenty-four (50%) patients had a failure of their first
operation and needed revision. The mean number of
revisions was 1.28 (0–15 times). The mean revision-free
time was 22 months (median 4.6 months, 1 day–9 years).
The follow-up period was 4.4 years (median 39 months).
Third ventriculostomies (ETV)
A total of 24 new ventriculostomies were performed. The
patients had a mean age of 6.1 years (median 6 years,
23 days to 17 years old). There were 7 girls and 17 boys.
Patients who had had their shunt inserted during the
inclusion period and had an ETV after the first shunt failure
were also considered in this category (two patients).
There were 11 patients with an aqueductal stenosis, 6
patients with a posterior fossa lesion (four posterior fossa
tumors and two cysts), 5 patients with a tectal or tegmental
lesion, and 2 patients with another obstructive etiology
(membranes in aqueduct after toxoplasmosis, Chiari I).
Eight patients had a failure of their ventriculostomy
(33%), leading to a new procedure. In three cases, they
underwent a re-ventriculostomy, whereas five patients had a
VPS implanted. The mean revision-free time was 19 months
(median 1 month, 13 days–9 years). The mean number of
revisions was 0.33 times (0–1 times). The follow-up period
was 45 months (median 33 months, 14 days–14 years).
Ventriculoperitoneal shunts
A total of 31 new VPS were placed. The patients were
3.5 years old on average (median 5 months, 1 day to
16.5 years old). There were 17 girls and 14 boys. The
patients who underwent a VPS after a ventriculostomy
failure are included, when the first treatment (ETV) was
done during the inclusion’s period (three patients).
There were ten patients with a posterior fossa lesion
(five tumoral lesions, three hemorrhagic lesions, two
cysts), four patients with a tectal or tegmental lesion,
eight patients with an aqueductal stenosis, and nine
patients with another obstructive etiology (one Chiari I
malformation, one with aqueductal membranes after
toxoplasmosis, seven myelomeningoceles).
Sixteen patients had a shunt failure (52%) and 11
underwent a shunt replacement, whereas 5 underwent a
ventriculostomy. The mean revision-free time was
24 months (median 7 months, 1 day–8.8 years). The mean
number of revisions was 1.6 times (0–15 times). The cause
of the first failure was disconnection in two cases, proximal
occlusion in five cases, distal occlusion in one case, valve
dysfunction in three cases, and infection in two cases (6%
of the total procedures and 11% of the patients needing
revision). In three cases, we were not able to retrieve the
cause of failure from the data. The follow-up period was
57.5 months (median 50 months, 10 days–11.5 years).
Comparison of the two groups
There were slightly more boys in the ventriculostomy group
and more girls in the VPS group. The age was not
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significantly different between the two procedures, but
tended to be younger for the shunted patients (p=0.09). The
distribution of etiologies is slightly different between the
two groups; however, they are all considered as obstructive
hydrocephalus (Fig. 1).
The number of revisions per patient was higher for the
VPS group (p=0.06). There was a slightly longer follow-up
period in the VPS group (mean 57 months vs 45 months,
p=0.31), as this procedure has been performed for a longer
time in the two hospitals and only progressively replaced
by ETV.
In the ETV group, 8 of 24 patients (33%) needed a
revision, whereas 17 of 33 (52%) of the VPS group had a
shunt failure. The revision-free time is not significantly
different between the two procedures (24 months for VPS
and 19 months for ETV, p=0.75), but tends to be longer in
the VPS group.
The majority of patients in the ETV group underwent
only one procedure, although some had a second procedure
after closure of the first ventriculostomy. In the VPS group,
even if a majority underwent only one procedure, some
patients had to undergo more than ten operations.
The number of revisions shows a lower number of
revisions in the ETV group per patient; however, there
might be a bias, as only three children benefited from a re-
intervention consisting of ETV, and all the other ETV
failures underwent VPS placement.
The primary cause of failure in the ETV group was closure
of the ventriculostomy, although there might have been a bad
appreciation of the underlying physiopathology and an
associated mal-resorptive hydrocephalus in a few cases. In
VPS patients, shunt failure resulted from proximal or distal
occlusion, disconnection, valve dysfunction, or infection.
If the percentage of patients free of revisions is
considered over time, with definite follow-up period at
6 months, 1, 2, and 5 years after the initial surgery, the
dynamic of revisions can be better understood and is shown
in Table 1.
There were no statistical differences between the two
procedures when analyzing the percentage of patients being
revision-free or needing a revision at 6 months, 1, 2, or 5 years
(Table 1). The respective failure rates at 2, 5, and 10 years
were 26, 26, and 30% for ETV and 34, 42, and 51% for
VPS, respectively. Although the majority of patients had a
follow-up greater than a year (mean follow-up, 52 months;
median, 39 months), a number of patients did not reach 2–
5 years, and some others were lost to follow up.
There is a constant decrease in the Kaplan–Meier
survival curve (Fig. 2) until 1 year for the VPS patients,
then a slowing of that curve. For the ETV patients, there is
a rapid decrease at the beginning (first 2 months), then a
decrease in the slope, and finally, a constant number. The
difference between the two curves is not statistically
different. The mean time until first revision is 18 months
(median 1.1 months) for ETV, whereas it is 24 months
(median 8.8 months) for VPS (p=0.75).
There were three unrelated deaths, one in the ETV and
two in the VPS group: In all cases, they were at the end-
point of tumor progression
Complications There were no major complications in this
series, but three children in the ETV group and one in the
VPS group developed sub-dural hematomas. In one case of
each group, the sub-dural hematoma had to be drained
because it had a significant mass effect and led to clinical
symptoms. Some patients underwent over- or under-
drainage, sometimes handled with an adjustable valve and
sometimes needing a surgical intervention, but those
patients, as well as the misplaced shunts, have been
analyzed in the failures and not in the complications.
Literature
A total of 27 studies were found that included 3,768 VPS
patients and 1,624 ETV patients in total. Seventeen series
analyzed ETV, seven studies examined shunts alone, and three
Table 1 Percentage of patients who were revision-free
Pediatric 6 months 1 year 2 years 5 years
ETV 70% 65% 52% 30%
VPS 77% 66% 55% 24%
p=0.61 p=0.87 p=0.94 p=0.61
Percentage of patients being revision-free over time for both the ETV
and the VPS group. Although there is no significant differences,
there is a trend toward less patients needing a revision in the ETV
group. At 5 years, there is a sudden drop in both groups due to the
fact that some of the patients in the study did not reach this follow-up












Fig. 1 Etiology of hydrocephalus: There is a majority of cases with
aqueductal stenosis in the ETV group, whereas in the VPS group,
posterior fossa lesion and other types of lesions are predominant. PF
posterior fossa lesion, AS aqueductal stenosis, TL tectal/tegmental
lesion, O other
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studies compared the two procedures (Table 2) [2–4, 6, 10, 12,
14, 15, 20–22, 25–30, 32, 33, 35, 36, 39–41, 43–45]. As
previously stated, meta-analysis could not be performed.
However, a mean failure rate can be obtained when adding all
the series and weighting them according to their sample size.
A grouping of all patients from the pediatric series
published who had benefited from a ventriculostomy
revealed a failure rate of 44%. The same analysis with the
children who had benefited from a shunt indicated a mean
failure rate of 49% (p<0.05). These numbers are only
indications, as there is a large amount of variability in the
populations studied in these articles.
In articles reporting ventriculostomies, the failure rate
ranges between 8 and 69%, or between 8 and 47% when
the series including infants are excluded. When the follow-
up of the series is greater than 2 years, the lowest failure
rate is 15%. In series of VPS, the failure rate range is 27 to
70%, and 56 to 70% when only analyzing series with a
follow-up greater than 2 years. Once again, the failure rate
is on the higher side when infants are considered (63%)
[33]. It is important to note that most of the third
ventriculostomy series do not consider operations that were
planned, but abandoned, during the procedure for technical
difficulties or complications, as failures. Only a few series
mentioned the number of procedures planned but not
achieved, and in those series, the ventriculostomy was not
possible in 3.4–7% of patients. This contrasts the series on
VPS, where all patients are accounted for (a drain in a
wrong position would be considered as a failure, as there is
a need for a second operation).
Discussion
The management of hydrocephalus is a never-ending
problem, and many studies analyzed the treatment options
and outcomes [5, 19, 20, 24, 28, 34, 37, 45]. Endoscopic
procedures increased in popularity because they provide the
opportunity for the patient to be shunt-free. At first,
indications for third ventriculostomies were restricted to
obstructive hydrocephalus, but some literature suggests that
it might also be expanded to some cases of non-obstructive
hydrocephalus [7, 16]. However, the hope of being cured
should not be confused with being shunt-free. Hydroceph-
alus might be treated with an ETV; however, the stomy
might fail as would a VPS. Progressively, ETV has been
replacing VPS as a treatment for obstructive hydrocephalus,
with the belief that no shunt is better than the best shunt. In
the series reported herein, all cases had an obstructive
hydrocephalus, but sometimes, the pathophysiology behind
the hydrocephalus might not be understood, and apprecia-
tion of the situation might be difficult (some resorption
malfunction might be added to the obstructive etiology).
In our series, at 3 years (median follow-up being
3.25 years), the failure rate of ventriculostomy is 26%,
whereas it is 38% for VPS (p=0.35); although there are
statistical differences, there is a trend toward lower failure
rate in the ETV group. In literature, the rate of failure of
ETV in the literature is highly variable (8–69%) [4–6, 18,
39]. The rate of failure in ventriculoperitoneal patients is
highly variable as well (27–70%) [8, 9, 24, 28, 37]. The
success of both procedures might vary depending on the
ETV vs VPS Kaplan-Meier survival's curve
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Fig. 2 Kaplan–Meier survival
curve plotted for VPS and
ETV. There is a rapid decrease
in the first 3 months for ETV,
and then a relative plateau,
whereas there is a more constant
decrease in the VPS group
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age of the patient, with a higher failure rate for infants [4, 8,
15, 27, 33, 42].
The difference in failure rate between ETV and VPS in
the first 6 months of follow-up might reveal either technical
difficulties in the ETV group (small space in front of basilar
artery, arachnoid membranes lower down the clivus,...) or a
bad appreciation in the selection of the patient for the
operation [13]. Unfortunately, late failures do occur in both
groups, as evidenced by reports of sudden deaths in the
literature [40, 17]. This implies that long-term follow-up is
needed in all patients, and that children who underwent
ETV cannot be considered as cured.
Procedure-related complications that are reported in the
literature are also different between the two procedures,
with more major complications reported with ETV such as
basilar artery perforation and diabetes insipidus [1, 3, 17,
29, 34]. On the other hand, some of the complications are
the same for both procedures, including infections that
sometimes lead to fatal meningitis. The reported complica-
tion rate varies from 6 to 11% [1, 29, 34]. The
complications encountered in our series of ventriculosto-
mies are similar to those found in the literature.
It has been questioned whether shunt infections might
affect the IQ [23, 31, 38], but to our knowledge, there have
been no studies done on cognitive dysfunction after
ventriculostomy failure. A rare, but fatal complication in
the treatment of hydrocephalus is an acute dysfunction with
a rapid increase in intracranial pressure and sudden death,










Failure rate VPS FU
Piatt and Carlson [30] 727 ped 73 months
(median survival)
Robinson et al. [33] 158 <1 years 63% 5 years 39.8 months
Vinchon et al. [41] 1564 29.3 months 70% 10.7 years
Tuli et al. [40] 717 1.5 years 56% 11 years
Aryan et al. [2] 11 4.5 years 27% 19 months
Kestle and Walker [25] 201 33% 1 year
Warf [43] 152 46, 00% 1 year
Jones et al. [21] 24 8.4 years 38
Cinalli et al. [6] 213 28 45 months
Kim et al. [26] 32 5.2 years 19 19 months
Beems and
Grotenhuis [4]
66 5 months 47 4 years
Mohanty et al. [28] 72 ? (ped) 18 15 months
Wellons et al. [45] 13 10 years 15 31 months
Singh et al. [35] 29 0–2 years 28 1–18 months
Smyth et al. [36] 12 9.2 years 33 20 months
Gorayeb et al. [15] 36 4.7 months 36 47 months
Koch and Wagner [27] 16 3 months 69 29 months, median 25
Baykan et al. [3] 210 2 months–10 years 8.10 3 months
Etus and Ceylan [10] 25 6 months 44 1 year, 8 months
Fritsch et al. [12] 18 4.9 months 61 50 months
Kadrian et al. [22] 22 (6–24 months)
0–78 years
42 5 years
Ray et al. [32] 43 30 24 months
Warf [44] 550 14.5 years 44 14.3 months
Navarro et al. [29] 136 37 3.3 years
Tuli et al. [39] 32 210 8.1 years 3.6 years 44 45% 1 to 11 years
Javadpour et al. [20] 21 26 6 weeks (median) 2 weeks (median) 67 na 18 months
Garton et al. [14] 28 28 46 60% 34.7 months
Twenty-seven studies were found in the literature.
Nb ETV/VPS number of patients included in the study who underwent ETV/VPS. Mean age ETV/VPS mean age at which the procedure was done.
Failure rate ETV/VPS the failure rate in percentage. FU the mean follow-up (when not available, the range is given). na not available. ped
pediatric series
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which might occur many months or years after the
procedure, and seems to happen more frequently in ETV
[17] than in shunting procedures [19, 40]. One hypothesis is
that, in shunted patients, there is a progressive dysfunction
of the shunt, with either some drainage around the shunt in
obstructive failure or within the fibrotic tunnel in discon-
nection. A second reason might be the patient’s and family
perception of the disease: Although they are well aware of
any symptoms that might be caused by shunt dysfunction,
and react promptly by coming to the attention of a medical
care giver, there might be a popular and medical belief that
third ventriculostomy is a one-time curative procedure, and
therefore, the patients or their families might not react to the
first signs of re-obstruction. Therefore, follow-up of
patients is necessary in all cases, but the management of
the patients might not be exactly the same. For example,
ETV might not change the size of the ventricles, and the
patency of the stomy has to be assessed (with 2-D cine
phase contrast or T2-weighted fast spin echo) [11], whereas
in the follow-up of shunts, ventricular size might be
assessed, as well as continuity of the shunt [24].
Conclusion
Our personal series does not enable us to state that third
ventriculostomy is a better treatment for obstructive hydro-
cephalus than shunt. However, there is a tendency in long-
term follow-up for ventriculostomy to be associated with less
revisions and a larger revision-free time. The same trend,
with a lower failure rate, is seen in the literature. However,
the morbidity associates to the procedure, according to
literature, might be higher in ventriculostomies than in VPS.
We would, therefore, advise to carefully select the patients in
which ETVmight be of benefit and to keep it as the treatment
of choice in obstructive hydrocephalus of those patients.
Patient awareness is extremely important, as late
obstruction might occur with both procedures. The patients
and their families should be followed on long-term basis
and informed on signs and symptoms that might occur in
recurring hydrocephalus.
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